January 6, 2010
Sequoia Capital invested $15 Million Wednesday, January 6th, in Series A financing with Acton Pharmaceuticals, Inc. for the inhalant AEROSPAN. This inhalant is a new type of aerosol inhalant that lacks the CFC base that older inhalants used to have. These types of inhalants are popping up in pharmacies all over the globe because they are more environmentally safe.
As one of the worldâ€™s leading venture capital funds for companies, Sequoia Capital invests in all different types of startup companies from energy to technology to healthcare services. They also invest $1-$10 million in early stage startups across the board. Sequoia also invests in growth stage companies of the same spectrum.
Sequoia invests millions of dollars per year so that companies can have the financing to take their ideas to the next level. Most of the founders of this venture capital firm were developers of products from all these different categories as well. So, they know the difficulties of finding the Venture Capital to get a business idea off the ground.
Some of the companies that this Capital fund has financed are those such as Luxim, GameFly, HealthCentral, WeatherBug, FireEye, Rock You, You Tube, Widgetbox, MotoSport, and Rayspan among many others.
These companies were merely ideas and business plans when Sequoia Capital came into play and made them the businesses that they are today. Much the same as AEROSPAN and the company of Acton Pharmaceutical was not much more than an idea when they introduced themselves to this huge venture capital firm.
There are hundreds of venture capital firms that offer funding in the pharmaceutical industry. However, the competition is generally steep when it comes to receiving funding for a new drug because this industry is one of the biggest in the U.S. Pharmaceutical companies from around the world are marketing new drugs every day which need the funding of these firms.
You can read much more about Acton Pharmaceutical and what they stand for at their website: http://actonpharmaceuticals.com/. This website shows the company business plan and what they plan to do. They became established two years ago and are actively growing due to the funding from venture capital firms.
Acton was founded by Daniel L. Kreisler and John W. Simon in 2008. Forest Laboratories, Inc. is the partner which Acton has entered into the agreement with to develop and commercialize their new, environmentally safer inhaled corticosteroid (ISC).
The pharmaceutical industry is well known for being a huge industry with plenty of room for growth. The market is thriving in the United States where this company is located due to the increasing interest of the people in life extension and the treatment of diseases to make this extension of life possible.